FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Existential restriction modifier
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Piroxicam 0.5% gel (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 25micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 50micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 75micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Fentanyl 100micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Laurilsulfate Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Laurilsulfate 10% solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Laurilsulfate 10% solution in water (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Sodium lauryl sulphate 10% in water (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dovobet ointment (Sigma Pharmaceuticals Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% cream (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% cream (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 0.5% ointment (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5% ointment (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoconazole 2% shampoo (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ketoprofen 2.5% gel (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 5% gel (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuprofen 10% gel (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    FemSeven Sequi 50micrograms/24hours Phase 1 patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    FemSeven Sequi Phase 2 patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Neupro 4mg/24hours transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (Auden McKenzie (Pharma Division) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    ChloraPrep with Tint solution 3ml applicators (Becton, Dickinson UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    ChloraPrep with Tint solution 10.5ml applicators (Becton, Dickinson UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    ChloraPrep with Tint solution 26ml applicators (Becton, Dickinson UK Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Boots Pharmacy Thrush 1% cream (The Boots Company Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% lotion (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Neupro 2mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Neupro 4mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Neupro 6mg/24hours transdermal patches (Sigma Pharmaceuticals Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dalacin T 1% topical solution (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dalacin T 1% topical lotion (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 75micrograms/24hours patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Eumovate 0.05% ointment (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Evorel Conti patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Locoid 0.1% scalp lotion (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Otomize ear spray (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transtec 35micrograms/hour transdermal patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transtec 52.5micrograms/hour transdermal patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transtec 70micrograms/hour transdermal patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Evorel 50 patches (Lexon (UK) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (A A H Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Mometasone 0.1% ointment (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Loceryl 5% nail lacquer (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dovonex 50micrograms/ml scalp solution (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Transtec 70micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Rozex 0.75% cream (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Rozex 0.75% gel (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Silkis ointment (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Voltarol 1% Emulgel (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 75micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 50micrograms/24hours patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Zovirax 5% cream (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dalacin T 1% topical solution (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 5 transdermal patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 10 transdermal patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dermovate 0.05% cream (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Dovobet ointment (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% cream (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% ointment (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Elocon 0.1% scalp lotion (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estraderm TTS 100 patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estraderm TTS 25 patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 75micrograms/24hours patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 50micrograms/24hours patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Estradot 37.5micrograms/24hours patches (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Lamisil 1% cream (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% cream (Co-Pharma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 1% ointment (Co-Pharma Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Ibuleve Speed Relief Max Strength 10% gel (Diomed Developments Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Derma Care Hydrocortisone 1% cream (The Boots Company Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Beclometasone 0.025% ointment (Essential Generics Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Beclometasone 0.025% cream (Essential Generics Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Loceryl 5% nail lacquer (Necessity Supplies Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Erythromycin 4% gel (Special Order) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Cocois ointment (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 10 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Deponit 5 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Durogesic DTrans 100 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Durogesic DTrans 25 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Durogesic DTrans 50 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Durogesic DTrans 75 transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Evorel Conti patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Isotrex 0.05% gel (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Powergel 2.5% gel (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Silkis ointment (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Scopoderm TTS 1.5mg patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Xamiol gel (Mawdsley-Brooks & Company Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Evorel 50 patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Beclometasone 0.025% cream (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Beclometasone 0.025% ointment (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g cream (Essential Generics Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Clobetasol 0.5mg / Neomycin 5mg / Nystatin 100,000units/g ointment (Essential Generics Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone 2.5mg muco-adhesive buccal tablets sugar free (Sigma Pharmaceuticals Plc) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Hydrocortisone Bite and Sting Relief 1% cream (Galpharm International Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier
    Galpharm Athletes Foot 1% cream (Galpharm International Ltd) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Existential restriction modifier

    Start Previous Page 50 of 55 Next End


    This concept is not in any reference sets

    Back to Start